Darko Kocjan

723 total citations
41 papers, 608 citations indexed

About

Darko Kocjan is a scholar working on Molecular Biology, Spectroscopy and Organic Chemistry. According to data from OpenAlex, Darko Kocjan has authored 41 papers receiving a total of 608 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 14 papers in Spectroscopy and 11 papers in Organic Chemistry. Recurrent topics in Darko Kocjan's work include Analytical Chemistry and Chromatography (7 papers), Mass Spectrometry Techniques and Applications (6 papers) and Analytical Methods in Pharmaceuticals (5 papers). Darko Kocjan is often cited by papers focused on Analytical Chemistry and Chromatography (7 papers), Mass Spectrometry Techniques and Applications (6 papers) and Analytical Methods in Pharmaceuticals (5 papers). Darko Kocjan collaborates with scholars based in Slovenia, China and Hungary. Darko Kocjan's co-authors include D. Hadži, Lennart Bergström, Giovanni Camino, Federico Carosio, Bernd Wicklein, Franc Avbelj, Robert L. Baldwin, U. Urleb, Adolf Miklavc and J. Kidrič and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Chemistry of Materials.

In The Last Decade

Darko Kocjan

39 papers receiving 584 citations

Peers

Countries citing papers authored by Darko Kocjan

Since Specialization

Citations

This map shows the geographic impact of Darko Kocjan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Darko Kocjan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Darko Kocjan more than expected).

Fields of papers citing papers by Darko Kocjan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Darko Kocjan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Darko Kocjan. The network helps show where Darko Kocjan may publish in the future.

Co-authorship network of co-authors of Darko Kocjan

This figure shows the co-authorship network connecting the top 25 collaborators of Darko Kocjan. A scholar is included among the top collaborators of Darko Kocjan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Darko Kocjan. Darko Kocjan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pyridylethanol(phenylethyl)amines are non-azole, highly selective Candida albicans sterol 14α-demethylase inhibitors 2020 ·Bioorganic Chemistry ·(unknown), (unknown), Izidor Sosič, Martina Gobec, (unknown), Marija Ivanov, Marina Sokóvić, Darko Kocjan, Damjana Rozman, Simona Golič Grdadolnik	8
2	Furan-based benzene mono- and dicarboxylic acid derivatives as multiple inhibitors of the bacterial Mur ligases (MurC–MurF): experimental and computational characterization 2015 ·Journal of Computer-Aided Molecular Design ·Andrej Perdih, Martina Hrast, (unknown), Hélène Barreteau, Simona Golič Grdadolnik, Darko Kocjan, Stanislav Gobec, Tom Šolmajer, Gerhard Wolber	22
3	A novel 2-oxoindolinylidene inhibitor of bacterial MurD ligase: Enzyme kinetics, protein-inhibitor binding by NMR and a molecular dynamics study 2014 ·European Journal of Medicinal Chemistry ·(unknown), (unknown), Katja Kristan, U. Urleb, Darko Kocjan, Simona Golič Grdadolnik	10
4	Inhibition of Human Sterol Δ7-Reductase and Other Postlanosterol Enzymes by LK-980, a Novel Inhibitor of Cholesterol Synthesis 2010 ·Drug Metabolism and Disposition ·Jure Ačimovič, (unknown), (unknown), Ingemar Björkhem, Katalin Monostory, Pál Szabó, Jean‐Marc Pascussi, (unknown), U. Urleb, Darko Kocjan, Damjana Rozman	11
5	Modulation of hepatic transcriptome in the poloxamer p-407 hyperlipidemia mouse model 2009 ·Acta chimica slovenica ·Drago Kuzman, Klementina Fon Tacer, (unknown), (unknown), (unknown), (unknown), Darko Kocjan, U. Urleb, Damjana Rozman	2
6	Amlodipine Benzenesulfonate: A Mechanistic Investigation of Its Industrial Preparation via Detritylation of N-tritylamlodipine and Related NMR Studies 2009 ·Croatica Chemica Acta ·(unknown), Simona Golič Grdadolnik, Stanko Hočevar, Darko Kocjan, Janez Levec, Howard Maskill, (unknown), Jiří Pospíšil, Milan Potáček, U. Urleb, Janko Žmitek	1
7	Isolation and structure determination of oxidative degradation products of atorvastatin 2009 ·Journal of Pharmaceutical and Biomedical Analysis ·(unknown), (unknown), (unknown), (unknown), Janez Plavec, Darko Kocjan	23
8	Drug Interaction Potential of 2-((3,4-Dichlorophenethyl)(propyl)amino)-1-(pyridin-3-yl)ethanol (LK-935), the Novel Nonstatin-Type Cholesterol-Lowering Agent 2008 ·Drug Metabolism and Disposition ·Katalin Monostory, Jean‐Marc Pascussi, Pál Szabó, (unknown), (unknown), Jure Ačimovič, Darko Kocjan, Drago Kuzman, (unknown), Rita Bernhardt, Laśzló Kob́ori, Damjana Rozman	17
9	Novel cholesterol biosynthesis inhibitors targeting human lanosterol 14α-demethylase (CYP51) 2007 ·Bioorganic & Medicinal Chemistry ·(unknown), Jure Ačimovič, (unknown), Darko Kocjan, Klementina Fon Tacer, Damjana Rozman, U. Urleb	32
10	Synthesis, Conformation, and Stereodynamics of a Salt of 2-{[2-(3,4-Dichlorophenyl)- ethyl]propylamino}-1-pyridin-3-ylethanol 2005 ·The Journal of Organic Chemistry ·(unknown), Jože Grdadolnik, U. Urleb, Darko Kocjan, Simona Golič Grdadolnik	4
11	Protein chemical shifts arising from α-helices and β-sheets depend on solvent exposure 2004 ·Proceedings of the National Academy of Sciences ·Franc Avbelj, Darko Kocjan, Robert L. Baldwin	64
12	Electrospray ionization mass spectrometric investigation of ammonium ion complexes with anomeric 2,3‐O‐isopropylidene‐1α‐ and ‐1β‐D‐ribofuranosyl azides: anomeric and kinetic isotope effects in ammonium affinities 2001 ·Rapid Communications in Mass Spectrometry ·Bogdan Kralj, Darko Kocjan, J. Kobe	12
13	Effect of column temperature on the behaviour of some angiotensin converting enzyme inhibitors during high-performance liquid chromatographic analysis 2001 ·Journal of Chromatography B Biomedical Sciences and Applications ·(unknown), (unknown), Darko Kocjan, Lucija Zupančič‐Kralj	26
14	Reactivity of anomeric 1α‐ and 1β‐pentofuranosyl azide derivatives in ammonia chemical ionization 2001 ·Rapid Communications in Mass Spectrometry ·Bogdan Kralj, Darko Kocjan, J. Kobe	3
15	Metastable and Collision-activated Decomposition of Protonated Molecules of Isomeric N7- and N9-Substituted Purines in the Gas Phase 1997 ·Rapid Communications in Mass Spectrometry ·Bogdan Kralj, Dušan Žigon, Darko Kocjan, J. Kobe	5
16	On the interaction of the aromatic part of dopaminergic agonists with the receptor 1994 ·Journal of Medicinal Chemistry ·Darko Kocjan	6
17	On the fundamental difference in the thermodynamics of agonist and antagonist interactions with β-adrenergic receptors and the mechanism of entropy-driven binding 1990 ·Biochemical Pharmacology ·Adolf Miklavc, Darko Kocjan, (unknown), Jože Koller, D. Hadži	33
18	Ab initio calculations on the hydration of dimethylpyrazole and indazole. Solvent effects on tautomeric energies. 1988 ·Journal of Molecular Structure THEOCHEM ·(unknown), Darko Kocjan, D. Hadži	8
19	Dopaminergic pharmacophore of ergoline and its analogs. A molecular electrostatic potential study 1986 ·Journal of Medicinal Chemistry ·Darko Kocjan, Milan Hodošček, D. Hadži	12
20	Conformationally restricted dopamine congeners—a molecular mechanics-based study 1983 ·Journal of Pharmacy and Pharmacology ·Darko Kocjan, D. Hadži	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact